Virtus Kar Health Sciences Fund Institutional Class (HLHIX) Fund Details & Analysis

Fund Information

Fund Category Health

Fund Family Allianz Global Investors

Fund Style Large

ISIN US92837N6186

CUSIP 018922484

Inception Date 2002-02-05

Domicile United States

Country USA

Fiscal Year End June

NAV Chart

Fund Metrics

Net Assets $175.34 Million

Share Class Net Assets $13.22 Million

Expense Ratio 1.05%

Expense Ratio Date 2020-11-06

Dividend Yield 0.00%

Morning Star Rating -

Morning Star Risk Rating -

Morning Star Category -

Performance

YTD Return 0.10%

1-Year Return 3.14%

3-Year Return 1.45%

5-Year Return 2.74%

NAV $30.91

Previous Close Price $31.30

Last Update 2025-12-31

Dividend Information

Dividend Yield 0.00%

Dividend (ttm) 0.17

Dividend Growth -58.12%

Payout Frequency Annual

Ex-Dividend Date n/a

Ratings

Morning Star Rating -

Morning Star Risk Rating -

Morning Star Category -

Beta (5Y) 1.23

About Virtus KAR Health Sciences Fund Institutional Class

The fund seeks to achieve its objective by normally investing at least 80% of its net assets (plus borrowings made for investment purposes) in health sciences-related companies. The portfolio manager considers health sciences-related companies to include companies that design, manufacture or sell products or services used for or in connection with healthcare, medicine or life sciences. The fund will invest primarily in common stocks and other equity securities.

Detailed Metrics

Market Cap Distribution

AverageMarketCap 70505.85%

Giant 13.64%

Large 38.25%

Medium 33.93%

Micro 5.34%

Small 7.41%

Value & Growth Metrics

Book-Value Growth % 8.97%

Cash-Flow Growth % -2.44%

Dividend Yield % 0.94%

Historical Earnings % 3.99%

Long-Term Earnings % 8.79%

Asset Allocation

Type	Net %	Long %	Short %	Category Average	benchmark
Bond	0.00%	0.00%	0.00%	0.18%	0.00%
Cash	1.43%	1.43%	0.00%	1.44%	0.00%
Non US Stock	0.00%	0.00%	0.00%	8.38%	0.23%
Not Classified	0.00%	0.00%	0.00%	0.00%	0.00%
Other	0.00%	0.00%	0.00%	0.14%	0.00%
US Stock	98.57%	98.57%	0.00%	90.06%	99.77%

Top Holdings

Name	Weight	Owned	Change
Eli Lilly Co	13.63%	-	-
UnitedHealth Group Inc	4.00%	-	-
AbbVie Inc	6.32%	-	-
Vertex Pharmaceuticals Inc	4.36%	-	-
Merck Co Inc	4.27%	-	-
Edwards Lifesciences Corp	4.07%	-	-
McKesson Corp	4.85%	-	-
Cooper Cos Inc/The	3.83%	-	-
IDEXX Laboratories Inc	6.22%	-	-
Danaher Corp	3.81%	-	-
Intuitive Surgical Inc	4.61%	-	-
Zoetis Inc	3.90%	-	-
West Pharmaceutical Services Inc	4.54%	-	-
Mettler-Toledo International Inc	4.01%	-	-

See the full breakdown of HLHIX fund's asset allocation and top holdings .

Sector Weights

Category	Subcategory	Amount %	Category Avg	Stocks %	Benchmark
Bond Sector	Cash and Equivalents	0.00%	88.82%	100.00%	0.00%
Bond Sector	Corporate	0.00%	11.18%	0.00%	0.00%
Bond Sector	Derivative	0.00%	0.00%	0.00%	0.00%
Bond Sector	Government	0.00%	0.00%	0.00%	0.00%
Bond Sector	Municipal	0.00%	0.00%	0.00%	0.00%
Bond Sector	Securitized	0.00%	0.00%	0.00%	0.00%
Cyclical	Basic Materials	0.00%	0.00%	0.00%	0.00%
Cyclical	Consumer Cyclical	0.00%	0.00%	0.00%	0.00%
Cyclical	Financial Services	0.00%	0.02%	0.00%	0.00%
Cyclical	Real Estate	0.00%	0.14%	0.00%	0.00%
Defensive	Consumer Defensive	0.00%	0.00%	0.00%	0.00%
Defensive	Healthcare	100.00%	99.80%	0.00%	100.00%
Defensive	Utilities	0.00%	0.00%	0.00%	0.00%
Sensitive	Communication Services	0.00%	0.00%	0.00%	0.00%
Sensitive	Energy	0.00%	0.02%	0.00%	0.00%
Sensitive	Industrials	0.00%	0.01%	0.00%	0.00%
Sensitive	Technology	0.00%	0.00%	0.00%	0.00%

World Regions

Region	Subregion	Category Average	Stocks Percent	Benchmark
Americas	Latin America	-	-	-
Americas	North America	91.79%	100.00%	99.77%
Greater Asia	Asia Developed	0.09%	-	-
Greater Asia	Asia Emerging	0.10%	-	-
Greater Asia	Australasia	0.07%	-	-
Greater Asia	Japan	0.40%	-	-
Greater Europe	Africa/Middle East	0.26%	-	-
Greater Europe	Europe Developed	5.28%	-	0.10%
Greater Europe	Europe Emerging	-	-	-
Greater Europe	United Kingdom	2.01%	-	0.13%

Dividend History

Date	Amount	Unadjusted Amount	Currency	Declaration Date	Record Date	Payment Date	Period
2022-12-21	$2.627	$2.627	USD	2022-12-21	2022-12-20	2022-12-21	Other
2021-12-16	$7.485	$7.485	USD	2021-12-16	2021-12-15	2021-12-16	Annual
2020-12-17	$5.020	$5.020	USD	2020-12-17	2020-12-16	2020-12-17	Annual
2019-12-19	$0.039	$0.039	USD	2019-12-19	2019-12-18	2019-12-19	Other
2018-12-20	$0.413	$0.413	USD	2018-12-20	2018-12-19	2018-12-20	Other

Related Funds to Explore

Nuveen Strategic Municipal Opportunities Fund Class A (NSAOX) fund overview	View NMEDX fund performance & NAV
FPPJX mutual fund analysis	Check BIBTX expense ratio & ratings
Fidelity SAI U.S. Large Cap Index Fund fund metrics & details	Explore APHYX investment profile
ANNPX fund yield & return data	Review Voya International High Dividend Low Volatility Portfolio Class A fund information
GUMAX morning star rating & risk analysis	Compare FDTIX fund sector allocation
JPMorgan Floating Rate Income Fund Class A net assets & portfolio breakdown	Analyze FIHAX fund value & growth metrics
FIJGX asset allocation & world regions	Get J.P. Morgan Exchange-Traded Fund Trust - JPMorgan Mortgage-Backed Securities ETF (JMBUX) complete fund report

Virtus KAR Health Sciences Fund Institutional Class NMFQS:HLHIX